Intelligence · Clinical Pipeline
Vir Biotechnology Pipeline
All ClinicalTrials.gov programs at Vir Biotechnology — phase, modality, and trial IDs.
- Programs
- 7
Quick answer
Vir Biotechnology has 7 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
LY3819253
Vir Biotechnology
Covid19
1 trial -
Tobevibart
Vir Biotechnology
Viral Hepatitis
3 trials -
VIR-2218, VIR-3434, HEPCLUDEX 2 mg powder for solution for injection
Vir Biotechnology
Chronic Hepatitis D Virus (HDV) Infection
1 trial -
VIR-3434, VIR-2218
Vir Biotechnology
Chronic Hepatitis D Virus (HDV) Infection
1 trial -
VIR-7831
Vir Biotechnology
COVID-19
1 trial -
VIR-7831 (sotrovimab)
Vir Biotechnology
Covid19
1 trial -
sotrovimab
Vir Biotechnology
Covid19
3 trials
Frequently asked questions
How many pipeline programs does Vir Biotechnology have?
7 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs